Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Oct 30 2020 | PhRMA Foundation Launches Valuing Health Equity Challenge Award Practice News In The News Read More Oct 27 2020 | New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status Industry News Industry Read More Oct 20 2020 | New HFSA Resources on Disparities in Heart Failure Now Available HFSA News Heart Failure Awareness 365 Provider Education Read More Oct 13 2020 | Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Industry News Industry Read More Oct 7 2020 | HFSA Submits Comments in Response to CY 2021 Medicare Physician Fee Schedule Proposed Rule HFSA News Advocacy Read More Pagination First page « First Previous page ‹ Previous … Page 88 Page 89 Page 90 Page 91 Current page 92 Page 93 Page 94 Page 95 Page 96 … Next page Next › Last page Last »
Oct 30 2020 | PhRMA Foundation Launches Valuing Health Equity Challenge Award Practice News In The News Read More
Oct 27 2020 | New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status Industry News Industry Read More
Oct 20 2020 | New HFSA Resources on Disparities in Heart Failure Now Available HFSA News Heart Failure Awareness 365 Provider Education Read More
Oct 13 2020 | Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Industry News Industry Read More
Oct 7 2020 | HFSA Submits Comments in Response to CY 2021 Medicare Physician Fee Schedule Proposed Rule HFSA News Advocacy Read More
